Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 131 | Allegiant Travel Co (ALGT) | XNAS | US | 2024-12-31 | 3 days ago | USD | 89.95 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 132 | Aptevo Therapeutics Inc (APVO) | XNAS | US | 2024-12-31 | 3 days ago | USD | 9.45 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 133 | Acorda Therapeutics Inc (ACOR) | XNAS | US | 2022-12-31 | 1 year ago | USD | 1.35 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 134 | Ares Commercial Real Estate Corp (ACRE) | XNYS | US | 2024-12-31 | 3 days ago | USD | 5.11 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 135 | Aclaris Therapeutics Inc (ACRS) | XNAS | US | 2024-12-31 | 3 days ago | USD | 2.62 | 0.00 | 0.00% | 0.57 | 21.65% | Ungraded | 0.00 | 0.00% |
| 136 | AcelRx Pharmaceuticals Inc (ACRX) | XNAS | US | 2022-12-31 | 2 years ago | USD | 0.99 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 137 | Acacia Research Corp (ACTG) | XNAS | US | 2024-12-31 | 3 days ago | USD | 3.81 | 0.00 | 0.00% | 1.86 | 48.80% | NCAV (Net-Net) | 1.86 | 48.80% |
| 138 | Amarin Corporation PLC (AMRN) | XNAS | IE | 2024-12-31 | 3 days ago | USD | 14.78 | 0.00 | 0.00% | 381.17 | 2,578.98% | Ungraded | 0.00 | 0.00% |
| 139 | Adaptimmune Therapeutics PLC (ADAP) | XNAS | GB | 2024-12-31 | 2 months ago | USD | 0.06 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 140 | Ayala Pharmaceuticals Inc (ADXS) | OOTC | US | 2023-12-31 | 3 days ago | USD | 0.46 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |